{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:07:42Z","timestamp":1770278862994,"version":"3.49.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Gamma interferon release assays (IGRAs) are increasingly used for latent<jats:named-content content-type=\"genus-species\">Mycobacterium tuberculosis<\/jats:named-content>infection (LTBI) screening in patients with rheumatic diseases starting anti-tumor necrosis factor (anti-TNF) therapies. We compared the performances of two IGRAs, an enzyme-linked immunospot release assay (T-SPOT.TB) and an enzyme-linked immunosorbent assay (QuantiFERON-TB Gold In Tube [QFT-GIT]), to that of tuberculin skin testing (TST) for LTBI screening of 157 consecutive rheumatic patients starting anti-TNF therapies. Among 155 patients with valid results, 58 (37%) were positive by TST, 39 (25%) by T-SPOT.TB assay, and 32 (21%) by QFT-GIT assay. IGRAs were associated more strongly with at least one risk factor for tuberculosis (TB) than TST. Risk factors for a positive assay included chest X-ray findings of old TB (TST), advanced age (both IGRAs), origin from a country with a high TB prevalence, and a positive TST (T-SPOT.TB assay). Steroid use was negatively associated with a positive QFT-GIT assay. The agreement rate between IGRAs was 81% (kappa rate = 0.47), which was much higher than that observed between an IGRA and TST. If positivity by either TST or an IGRA was required for LTBI diagnosis, then the rate of LTBI would have been 46 to 47%, while if an IGRA was performed only for TST-positive patients, the respective rate would have been 11 to 17%. In conclusion, IGRAs appear to correlate better with TB risk than TST and should be included in TB screening of patients starting anti-TNF therapies. In view of the high risk of TB in these patients, a combination of one IGRA and TST is probably more appropriate for LTBI diagnosis.<\/jats:p>","DOI":"10.1128\/cvi.05299-11","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T04:00:07Z","timestamp":1318478407000},"page":"2102-2108","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":51,"title":["Comparison of Two Gamma Interferon Release Assays and Tuberculin Skin Testing for Tuberculosis Screening in a Cohort of Patients with Rheumatic Diseases Starting Anti-Tumor Necrosis Factor Therapy"],"prefix":"10.1128","volume":"18","author":[{"given":"Dimitrios","family":"Vassilopoulos","sequence":"first","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stamatoula","family":"Tsikrika","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrisoula","family":"Hatzara","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varvara","family":"Podia","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kandili","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Stamoulis","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Hadziyannis","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, Hippokration General Hospital, Athens University School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161:S221\u2013S247.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi F.","year":"2009","unstructured":"BartalesiF.. 2009. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur. Respir. J. 33:586\u2013593.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_2_4_2","first-page":"620","article-title":"Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy","volume":"137","author":"Beglinger C.","year":"2007","unstructured":"BeglingerC.. 2007. Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med. Wkly. 137:620\u2013622.","journal-title":"Swiss Med. Wkly."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3899\/jrheum.080854","article-title":"Use of the T-SPOT. TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy","volume":"36","author":"Behar S. M.","year":"2009","unstructured":"BeharS. M.. 2009. Use of the T-SPOT. TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. J. Rheumatol. 36:546\u2013551.","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment","volume":"27","author":"Bocchino M.","year":"2008","unstructured":"BocchinoM.. 2008. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur. J. Clin. Microbiol. Infect. Dis. 27:913.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0962-8479(95)90554-5","article-title":"Tuberculin sensitivity trends in Hellenic army recruits during the period 1981-91","volume":"76","author":"Bouros D.","year":"1995","unstructured":"BourosD.. 1995. Tuberculin sensitivity trends in Hellenic army recruits during the period 1981-91. Tuber. Lung Dis. 76:126\u2013129.","journal-title":"Tuber. Lung Dis."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000196476","article-title":"Incidence of tuberculosis in Greek armed forces from 1965-1993","volume":"62","author":"Bouros D.","year":"1995","unstructured":"BourosD.. 1995. Incidence of tuberculosis in Greek armed forces from 1965-1993. Respiration 62:336\u2013340.","journal-title":"Respiration"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Canadian Tuberculosis Committee. 2010. Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection\u20142010 update. Advisory Committee Statement (ACS) Canada Communicable Disease Report (CCDR) vol. 36 (ACS-5) p. 1\u201322. Canadian Tuberculosis Committee Canada. http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/10pdf\/36-acs-5.pdf. Accessed 7 April 2011.","DOI":"10.14745\/ccdr.v36i00a05"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi A.","year":"2011","unstructured":"CattamanchiA.. 2011. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J. Acquir. Immune Defic. Syndr. 56:230\u2013238.","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_11_2","first-page":"1177","article-title":"Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers","volume":"11","author":"Cobanoglu N.","year":"2007","unstructured":"CobanogluN.. 2007. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. Int. J. Tuberc. Lung Dis. 11:1177\u20131182.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel R.","year":"2011","unstructured":"DielR.. 2011. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37:88\u201399.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_2_13_2","first-page":"329","article-title":"Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases","volume":"63","author":"Diel R.","year":"2009","unstructured":"DielR. HauerB. LoddenkemperR. MangerB. KrugerK.. 2009. Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases. Pneumologie 63:329\u2013334.","journal-title":"Pneumologie"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel R.","year":"2010","unstructured":"DielR. LoddenkemperR. NienhausA.. 2010. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137:952\u2013968.","journal-title":"Chest"},{"key":"e_1_3_2_15_2","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat M.","year":"2006","unstructured":"FarhatM. GreenawayC. PaiM. MenziesD.. 2006. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int. J. Tuberc. Lung Dis. 10:1192\u20131204.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_16_2","first-page":"1751","article-title":"Management of tuberculosis in France: guidelines of the French Pulmonary Society","volume":"35","author":"French Pulmonary Society","year":"2006","unstructured":"French Pulmonary Society. 2006. Management of tuberculosis in France: guidelines of the French Pulmonary Society. Presse Med. 35:1751\u20131757.","journal-title":"Presse Med."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2334-6-102","article-title":"Prevalence and predictors of tuberculin skin positivity in Hellenic Army recruits","volume":"6","author":"German V.","year":"2006","unstructured":"GermanV. GiannakosG. KopteridesP. FalagasM. E.. 2006. Prevalence and predictors of tuberculin skin positivity in Hellenic Army recruits. BMC Infect. Dis. 6:102.","journal-title":"BMC Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.arbres.2010.02.010","article-title":"Consensus document on the diagnosis, treatment and prevention of tuberculosis","volume":"46","author":"Gonzalez-Martin J.","year":"2010","unstructured":"Gonzalez-MartinJ.. 2010. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Arch. Bronconeumol. 46:255\u2013274.","journal-title":"Arch. Bronconeumol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. Latent tuberculosis infection in the United States","volume":"364","author":"Horsburgh C. R.","year":"2011","unstructured":"HorsburghC. R.Jr. RubinE. J.. 2011. Clinical practice. Latent tuberculosis infection in the United States. N. Engl. J. Med. 364:1441\u20131448.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/BOR.0b013e3283025ec2","article-title":"Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies","volume":"20","author":"Keane J.","year":"2008","unstructured":"KeaneJ. BresnihanB.. 2008. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies. Curr. Opin. Rheumatol. 20:443\u2013449.","journal-title":"Curr. Opin. Rheumatol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3899\/jrheum.100623","article-title":"Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"38","author":"Keystone E. C.","year":"2011","unstructured":"KeystoneE. C. PappK. A. WobeserW.. 2011. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. J. Rheumatol. 38:1234\u20131243.","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/ard.2009.113829","article-title":"Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases","volume":"69","author":"Kleinert S.","year":"2010","unstructured":"KleinertS.. 2010. Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann. Rheum. Dis. 69:782\u2013784.","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay tuberculin skin test","volume":"161","author":"Laffitte E.","year":"2009","unstructured":"LaffitteE.. 2009. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay tuberculin skin test. Br. J. Dermatol. 161:797\u2013800.","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","article-title":"Comparison of interferon gamma release assays and conventional screening tests before tumour necrosis factor alpha blockade in patients with inflammatory arthritis","volume":"69","author":"Martin J.","year":"2010","unstructured":"MartinJ.. 2010. Comparison of interferon gamma release assays and conventional screening tests before tumour necrosis factor alpha blockade in patients with inflammatory arthritis. Ann. Rheum. Dis. 69:181\u2013185.","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis G.","year":"2008","unstructured":"MatulisG. JuniP. VilligerP. M. GadolaS. D.. 2008. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann. Rheum. Dis. 67:84\u201390.","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_3_2_26_2","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek M.","year":"2010","unstructured":"MazurekM.. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. MMWR Recomm. Rep. 59:1\u201325.","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_27_2","unstructured":"National Institute for Health and Clinical Excellence. 2011. Tuberculosis. Clinical diagnosis and management of tuberculosis and measures for its prevention and control. Clinical guideline 117. National Institute for Health and Clinical Excellence London United Kingdom. http:\/\/www.nice.org.uk\/nicemedia\/live\/13422\/53642\/53642.pdf. Accessed 7 April 2011."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai M.","year":"2008","unstructured":"PaiM. ZwerlingA. MenziesD.. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149:177\u2013184.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/rccm.201001-0083OC","article-title":"Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans","volume":"182","author":"Place S.","year":"2010","unstructured":"PlaceS.. 2010. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. Am. J. Respir. Crit. Care Med. 182:848\u2013854.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_30_2","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon D.","year":"2008","unstructured":"Ponce de LeonD.. 2008. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J. Rheumatol. 35:776\u2013781.","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester M.","year":"2011","unstructured":"SesterM.. 2011. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 37:100\u2013111.","journal-title":"Eur. Respir. J."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3899\/jrheum.081292","article-title":"Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases","volume":"36","author":"Soborg B.","year":"2009","unstructured":"SoborgB.. 2009. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. J. Rheumatol. 36:1876\u20131884.","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_33_2","first-page":"1271","article-title":"Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment","volume":"35","author":"Vassilopoulos D.","year":"2008","unstructured":"VassilopoulosD. StamoulisN. HadziyannisE. ArchimandritisA. J.. 2008. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J. Rheumatol. 35:1271\u20131276.","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_34_2","unstructured":"WHO. 2010. Global tuberculosis control 2010. WHO Geneva Switzerland. http:\/\/www.who.int\/tb\/publications\/global_report\/2010\/en\/index.html. Accessed 7 April 2011."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.05299-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.05299-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T14:41:35Z","timestamp":1639147295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.05299-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1128\/CVI.05299-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.05299-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"2011-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-10-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-11-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}